Healthcare

Circulating Tumor Cells Market Size to Rake US$ 20.3 billion by 2030

The global Circulating Tumor Cells market size is expected to be worth around US$ 20.3 billion by 2030, according to a new report by Vision Research Reports.

Circulating Tumor Cells Market (By Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis; By Application: Clinical/ Liquid Biopsy, Research; By Product: Kits & Reagents, Blood Collection Tubes, Devices or Systems; By Specimen: Blood, Bone Marrow, Other Body Fluids) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38319

Growth Factor

Many potential applications of CTCs in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products Research organizations are engaged in endeavors aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed.

Furthermore, the growing demand for minimally invasive diagnostic procedures is anticipated to propel investments by key stakeholders in this area. CTC-based liquid biopsy tests lead to limited trauma and enable rapid recovery owing to their non-invasive nature. Moreover, it enables minimal invasive screening of tumors before opting for complex surgical procedures, such as radiotherapy, chemotherapy, and surgical removal of tumors, thus positively impacting the adoption.

The circulating tumor cells market report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, market footprint, strategic developments, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.

This circulating tumor cells market report offers historical data points and forecasts and revenue growth at a global, regional, and country level, latest industry trends, and consumption pattern details for each region, major country, and segment from 2021 to 2030.

The market report also covers technical data, manufacturing and production costs, research and development activities, regulatory framework, economic factors, and globalization. The report further segments the circulating tumor cells market on the basis of Leading Companies Profiled, and key regions of circulating tumor cells market.

Key Players

  • QIAGEN
  • Bio-Techne Corporation
  • Precision for Medicine
  • AVIVA Biosciences
  • BIOCEPT, Inc.
  • BioCEP Ltd.
  • Fluxion Biosciences, Inc.
  • Greiner Bio One International GmbH
  • Ikonisys Inc.
  • Miltenyi Biotec
  • IVDiagnostics
  • BioFluidica
  • Canopus Bioscience Ltd.
  • Biolidics Limited
  • Creativ MicroTech, Inc.
  • LungLife AI, Inc.
  • Epic Sciences
  • Rarecells Diagnostics
  • ScreenCell
  • Menarini Silicon Biosystems
  • LineaRx, Inc. (Vitatex, Inc.)
  • Sysmex Corporation
  • STEMCELL Technologies, Inc.

Market Segmentation

  • Technology Outlook
    • CTC Detection & Enrichment Methods
      • Immunocapture (Label-based)
        • Positive Selection
        • Negative Selection
      • Size-based Separation (Label-free)
        • Membrane-based
        • Microfluidic-based
      • Density-based Separation (Label-free)
      • Combined Methods (Label-free)
    • CTC Direct Detection Methods
      • SERS
      • Microscopy
      • Others
    • CTC Analysis
  • Application Outlook
    • Clinical/ Liquid Biopsy
      • Risk Assessment
      • Screening and Monitoring
    • Research
      • Cancer Stem Cell & Tumorogenesis Research
      • Drug/Therapy Development
  • Product Outlook
    • Kits & Reagents
    • Blood Collection Tubes
    • Devices or Systems
  • Specimen Outlook
    • Blood
    • Bone Marrow
    • Other Body Fluids
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Singapore
      • Australia
    • Latin America
      • Brazil
      • Argentina
    • Middle East & Africa
      • South Africa
      • UAE

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38319

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Circulating Tumor Cells Market, By Technology

7.1.  Circulating Tumor Cells Market, by Technology, 2020-2030

7.1.1.    CTC Detection & Enrichment Methods

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    CTC Direct Detection Methods

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    CTC Analysis

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Circulating Tumor Cells Market, By Application

8.1.  Circulating Tumor Cells Market, by Application, 2020-2030

8.1.1.    Clinical/ Liquid Biopsy

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Research

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Circulating Tumor Cells Market, By Product

9.1.  Circulating Tumor Cells Market, by Product, 2020-2030

9.1.1.    Kits & Reagents

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Blood Collection Tubes

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Devices or Systems

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Circulating Tumor Cells Market, By Specimen

10.1.        Circulating Tumor Cells Market, by Specimen, 2020-2030

10.1.1.  Blood

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Bone Marrow

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Other Body Fluids

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Circulating Tumor Cells Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.1.2.  Market Revenue and Forecast, by Application (2016-2030)

11.1.3.  Market Revenue and Forecast, by Product (2016-2030)

11.1.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.2.2.  Market Revenue and Forecast, by Application (2016-2030)

11.2.3.  Market Revenue and Forecast, by Product (2016-2030)

11.2.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.3.2.  Market Revenue and Forecast, by Application (2016-2030)

11.3.3.  Market Revenue and Forecast, by Product (2016-2030)

11.3.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.4.2.  Market Revenue and Forecast, by Application (2016-2030)

11.4.3.  Market Revenue and Forecast, by Product (2016-2030)

11.4.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.5.2.  Market Revenue and Forecast, by Application (2016-2030)

11.5.3.  Market Revenue and Forecast, by Product (2016-2030)

11.5.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

Chapter 12.  Company Profiles

12.1.              QIAGEN

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Bio-Techne Corporation

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Precision for Medicine

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              AVIVA Biosciences

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              BIOCEPT, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              BioCEP Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Fluxion Biosciences, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Greiner Bio One International GmbH

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Ikonisys Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Miltenyi Biotec

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           IVDiagnostics

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           BioFluidica

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Canopus Bioscience Ltd.

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Biolidics Limited

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

12.15.           Creativ MicroTech, Inc.

12.15.1.               Company Overview

12.15.2.               Product Offerings

12.15.3.               Financial Performance

12.15.4.               Recent Initiatives

12.16.           LungLife AI, Inc.

12.16.1.               Company Overview

12.16.2.               Product Offerings

12.16.3.               Financial Performance

12.16.4.               Recent Initiatives

12.17.           Epic Sciences

12.17.1.               Company Overview

12.17.2.               Product Offerings

12.17.3.               Financial Performance

12.17.4.               Recent Initiatives

12.18.           Rarecells Diagnostics

12.18.1.               Company Overview

12.18.2.               Product Offerings

12.18.3.               Financial Performance

12.18.4.               Recent Initiatives

12.19.           ScreenCell

12.19.1.               Company Overview

12.19.2.               Product Offerings

12.19.3.               Financial Performance

12.19.4.               Recent Initiatives

12.20.           Menarini Silicon Biosystems

12.20.1.               Company Overview

12.20.2.               Product Offerings

12.20.3.               Financial Performance

12.20.4.               Recent Initiatives

12.21.           LineaRx, Inc. (Vitatex, Inc.)

12.21.1.               Company Overview

12.21.2.               Product Offerings

12.21.3.               Financial Performance

12.21.4.               Recent Initiatives

12.22.           Sysmex Corporation

12.22.1.               Company Overview

12.22.2.               Product Offerings

12.22.3.               Financial Performance

12.22.4.               Recent Initiatives

12.23.           STEMCELL Technologies, Inc.

12.23.1.               Company Overview

12.23.2.               Product Offerings

12.23.3.               Financial Performance

12.23.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38319

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button